Staar Surgical Shares Up 62% As Investors Glimpse ICL Clinical Data
Anticipation of strong three-year follow-up data on Staar Surgical's ICL phakic implants helped push the firm's stock up 61.5% in March
Anticipation of strong three-year follow-up data on Staar Surgical's ICL phakic implants helped push the firm's stock up 61.5% in March